Literature DB >> 19635576

Measuring arterial and tissue responses to functional challenges using arterial spin labeling.

Yi-Ching Lynn Ho1, Esben Thade Petersen, Xavier Golay.   

Abstract

The measurement of cerebral blood flow (CBF) in functional MRI studies that aim for non-invasive, quantitative and reliable measurements is a challenge. Here, we tested the feasibility of a recently developed, model-free CBF technique to study vascular dynamics upon functional challenges. Multiple inversion time-point signals were measured from arterial and tissue compartments, allowing for the calculation of CBF through a process of deconvolution. Using graded visual stimulation known to produce increasing hemodynamic responses, we recorded significant and graded DeltaCBF and Deltatau(m) (microvascular arrival time change) that were highly comparable to those estimated by a standard 3-parameter fit based on the general kinetic model, though the absolute values had weaker agreement. Estimated arterial blood volumes (excluding substantial arteriolar contribution) did not show significant change with visual stimulation. Bolus arrival times in the microvascular compartment shortened more as compared to the arrival times from the arterial compartment during visual stimulation, suggesting larger involvement of the microvasculature in local neuronal response. While there are limitations, the model-free analysis method has the potential to offer useful vascular information in fMRI studies.

Mesh:

Substances:

Year:  2009        PMID: 19635576     DOI: 10.1016/j.neuroimage.2009.07.040

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  9 in total

1.  Simultaneous measurement of cerebral blood flow and transit time with turbo dynamic arterial spin labeling (Turbo-DASL): application to functional studies.

Authors:  Yuguang Meng; Ping Wang; Seong-Gi Kim
Journal:  Magn Reson Med       Date:  2011-12-09       Impact factor: 4.668

2.  Quantification of arterial cerebral blood volume using multiphase-balanced SSFP-based ASL.

Authors:  Lirong Yan; Cheng Li; Emily Kilroy; Felix W Wehrli; Danny J J Wang
Journal:  Magn Reson Med       Date:  2011-11-29       Impact factor: 4.668

3.  Similarities and differences in arterial responses to hypercapnia and visual stimulation.

Authors:  Yi-Ching Lynn Ho; Esben Thade Petersen; Ivan Zimine; Xavier Golay
Journal:  J Cereb Blood Flow Metab       Date:  2010-08-11       Impact factor: 6.200

4.  Template-based approach for detecting motor task activation-related hyperperfusion in pulsed ASL data.

Authors:  Jan Petr; Jean-Christophe Ferré; Hélène Raoult; Elise Bannier; Jean-Yves Gauvrit; Christian Barillot
Journal:  Hum Brain Mapp       Date:  2013-02-13       Impact factor: 5.038

5.  Localized blood flow imaging using quantitative flow-enhanced signal intensity.

Authors:  Cheng Ouyang; Bradley P Sutton
Journal:  Magn Reson Med       Date:  2011-06-28       Impact factor: 4.668

6.  Pseudo-continuous transfer insensitive labeling technique.

Authors:  Cheng Ouyang; Bradley P Sutton
Journal:  Magn Reson Med       Date:  2011-03-04       Impact factor: 4.668

7.  Noninvasive assessment of arterial compliance of human cerebral arteries with short inversion time arterial spin labeling.

Authors:  Esther A H Warnert; Kevin Murphy; Judith E Hall; Richard G Wise
Journal:  J Cereb Blood Flow Metab       Date:  2014-12-17       Impact factor: 6.200

8.  The major cerebral arteries proximal to the Circle of Willis contribute to cerebrovascular resistance in humans.

Authors:  Esther A H Warnert; Emma C Hart; Judith E Hall; Kevin Murphy; Richard G Wise
Journal:  J Cereb Blood Flow Metab       Date:  2015-11-20       Impact factor: 6.200

9.  In vivo assessment of human brainstem cerebrovascular function: a multi-inversion time pulsed arterial spin labelling study.

Authors:  Esther A H Warnert; Ashley D Harris; Kevin Murphy; Neeraj Saxena; Neeta Tailor; Nigel S Jenkins; Judith E Hall; Richard G Wise
Journal:  J Cereb Blood Flow Metab       Date:  2014-03-05       Impact factor: 6.200

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.